Exploratory analyses to guide inclusion, limitation of sample size and strengthening of endpoints in clinical stroke trials
Clinical trials for treatment of acute ischaemic stroke require large numbers of patients and are expensive to conduct. Treatment is typically administered within the first hours or days after stroke onset. Outcome is usually assessed by a single measure, the most common being the modified Rankin sc...
Main Author: | |
---|---|
Published: |
University of Glasgow
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.578587 |